The DOI matches its Crossref record; 92 of the 92 references it cites were found in a registry or an index.
Hallmarks of alternative splicing in cancer
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
Hanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219
Warburg, O. (1956) · Science · doi:10.1126/science.123.3191.309 · Cited by 13,425
Bevacizumab plus Irinotecan, Fluorouracil, and Leucovorin for Metastatic Colorectal Cancer
Hurwitz, H., Fehrenbacher, L., Novotny, W., Cartwright, T., Hainsworth, J., Heim, W., Berlin, J., Baron, A., Griffing, S., Holmgren, E., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa032691 · Cited by 10,968
The basics of epithelial-mesenchymal transition
Kalluri, R., & Weinberg, R. A. (2009) · Journal of Clinical Investigation · doi:10.1172/jci39104 · Cited by 10,196
Alternative isoform regulation in human tissue transcriptomes
Wang, E. T., Sandberg, R., Luo, S., Khrebtukova, I., Zhang, L., Mayr, C., Kingsmore, S. F., Schroth, G. P., & Burge, C. B. (2008) · Nature · doi:10.1038/nature07509 · Cited by 5,181
Tumor Metastasis: Molecular Insights and Evolving Paradigms
Valastyan, S., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.09.024 · Cited by 4,011
Pan, Q., Shai, O., Lee, L. J., Frey, B. J., & Blencowe, B. J. (2008) · Nature Genetics · doi:10.1038/ng.259 · Cited by 3,951
On Respiratory Impairment in Cancer Cells
Warburg, O. (1956) · Science · doi:10.1126/science.124.3215.269 · Cited by 3,468
Inhibition of Mutated, Activated BRAF in Metastatic Melanoma
Flaherty, K. T., Puzanov, I., Kim, K. B., Ribas, A., McArthur, G. A., Sosman, J. A., O'Dwyer, P. J., Lee, R. J., Grippo, J. F., Nolop, K., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1002011 · Cited by 3,103
Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis
Skobe, M., Hawighorst, T., Jackson, D. G., Prevo, R., Janes, L., Velasco, P., Riccardi, L., Alitalo, K., Claffey, K., & Detmar, M. (2001) · Nature Medicine · doi:10.1038/84643 · Cited by 1,733
Joukov, V., Pajusola, K., Kaipainen, A., Chilov, D., Lahtinen, I., Kukk, E., Saksela, O., Kalkkinen, N., & Alitalo, K. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00359.x · Cited by 1,672
RAF inhibitor resistance is mediated by dimerization of aberrantly spliced BRAF(V600E)
Poulikakos, P. I., Persaud, Y., Janakiraman, M., Kong, X., Ng, C., Moriceau, G., Shi, H., Atefi, M., Titz, B., Gabay, M. T., et al. (2011) · Nature · doi:10.1038/nature10662 · Cited by 1,454
Kendall, R. L., & Thomas, K. A. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.22.10705 · Cited by 1,394
Rac1b and reactive oxygen species mediate MMP-3-induced EMT and genomic instability
Radisky, D. C., Levy, D. D., Littlepage, L. E., Liu, H., Nelson, C. M., Fata, J. E., Leake, D., Godden, E. L., Albertson, D. G., Angela Nieto, M., et al. (2005) · Nature · doi:10.1038/nature03688 · Cited by 1,284
HnRNP proteins controlled by c-Myc deregulate pyruvate kinase mRNA splicing in cancer
David, C. J., Chen, M., Assanah, M., Canoll, P., & Manley, J. L. (2010) · Nature · doi:10.1038/nature08697 · Cited by 1,179
Houck, K. A., Leung, D. W., Rowland, A. M., Winer, J., & Ferrara, N. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)35712-0 · Cited by 1,127
The gene encoding the splicing factor SF2/ASF is a proto-oncogene
Karni, R., de Stanchina, E., Lowe, S. W., Sinha, R., Mu, D., & Krainer, A. R. (2007) · Nature Structural & Molecular Biology · doi:10.1038/nsmb1209 · Cited by 934
Alternative pre-mRNA splicing regulation in cancer: pathways and programs unhinged
David, C. J., & Manley, J. L. (2010) · Genes & Development · doi:10.1101/gad.1973010 · Cited by 814
Aberrant and Alternative Splicing in Cancer
Venables, J. P. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-1910 · Cited by 634
Brown, R. L., Reinke, L. M., Damerow, M. S., Perez, D., Chodosh, L. A., Yang, J., & Cheng, C. (2011) · Journal of Clinical Investigation · doi:10.1172/jci44540 · Cited by 631
Immunohistochemical analysis of bcl-2, bax, bcl-X, and mcl-1 expression in prostate cancers.
Krajewska, M., Krajewski, S., Epstein, J. I., Shabaik, A. S., Sauvageot, J., Song, K. B., Kitada, S., & Reed, J. C. (1996) · Europe PMC (PubMed Central) · Cited by 593
ESRP1 and ESRP2 Are Epithelial Cell-Type-Specific Regulators of FGFR2 Splicing
Warzecha, C. C., Sato, T. K., Nabet, B., Hogenesch, J. B., & Carstens, R. P. (2009) · Molecular Cell · doi:10.1016/j.molcel.2009.01.025 · Cited by 579
(2002) · PubMed · Cited by 550
Shapiro, I. M., Cheng, A. W., Flytzanis, N. C., Balsamo, M., Condeelis, J. S., Oktay, M. H., Burge, C. B., & Gertler, F. B. (2011) · PLoS Genetics · doi:10.1371/journal.pgen.1002218 · Cited by 461
VEGF165b, an Inhibitory Vascular Endothelial Growth Factor Splice Variant
Woolard, J., Wang, W.-Y., Bevan, H. S., Qiu, Y., Morbidelli, L., Pritchard-Jones, R. O., Cui, T.-G., Sugiono, M., Waine, E., Perrin, R., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0934 · Cited by 451
Self-citationAnczuków, O., Rosenberg, A. Z., Akerman, M., Das, S., Zhan, L., Karni, R., Muthuswamy, S. K., & Krainer, A. R. (2012) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.2207 · Cited by 447
SR splicing factors serve as adapter proteins for TAP-dependent mRNA export
Huang, Y., Gattoni, R., Stévenin, J., & Steitz, J. A. (2003) · Molecular Cell · doi:10.1016/s1097-2765(03)00089-3 · Cited by 426
Joukov, V., Pajusola, K., Kaipainen, A., Chilov, D., Lahtinen, I., Kukk, E., Saksela, O., Kalkkinen, N., & Alitalo, K. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00521.x · Cited by 423
A novel role for shuttling SR proteins in mRNA translation
Sanford, J. R., Gray, N. K., Beckmann, K., & Cáceres, J. F. (2004) · Genes & Development · doi:10.1101/gad.286404 · Cited by 407
Lee, J., Gray, A., Yuan, J., Luoh, S. M., Avraham, H., & Wood, W. I. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.5.1988 · Cited by 401
Cell Motility Is Controlled by SF2/ASF through Alternative Splicing of the Ron Protooncogene
Ghigna, C., Giordano, S., Shen, H., Benvenuto, F., Castiglioni, F., Comoglio, P. M., Green, M. R., Riva, S., & Biamonti, G. (2005) · Molecular Cell · doi:10.1016/j.molcel.2005.10.026 · Cited by 389
An ESRP‐regulated splicing programme is abrogated during the epithelial–mesenchymal transition
Warzecha, C. C., Jiang, P., Amirikian, K., Dittmar, K. A., Lu, H., Shen, S., Guo, W., Xing, Y., & Carstens, R. P. (2010) · The EMBO Journal · doi:10.1038/emboj.2010.195 · Cited by 383
Albuquerque, R. J. C., Hayashi, T., Cho, W. G., Kleinman, M. E., Dridi, S., Takeda, A., Baffi, J. Z., Yamada, K., Kaneko, H., Green, M. G., et al. (2009) · Nature Medicine · doi:10.1038/nm.2018 · Cited by 357
Cancer-associated regulation of alternative splicing
Venables, J. P., Klinck, R., Koh, C., Gervais-Bird, J., Bramard, A., Inkel, L., Durand, M., Couture, S., Froehlich, U., Lapointe, E., et al. (2009) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.1608 · Cited by 342
Nowak, D. G., Woolard, J., Amin, E. M., Konopatskaya, O., Saleem, M. A., Churchill, A. J., Ladomery, M. R., Harper, S. J., & Bates, D. O. (2008) · Journal of Cell Science · doi:10.1242/jcs.016410 · Cited by 339
Self-citationElevated expression of Bcl-X and reduced Bak in primary colorectal adenocarcinomas.
Krajewska, M., Moss, S. F., Krajewski, S., Song, K. B., Holt, P. R., & Reed, J. C. (1996) · PubMed · Cited by 321
Maglione, D., Guerriero, V., Viglietto, G., Ferraro, M. G., Aprelikova, O. N., Alitalo, K. K., Vecchio, S. D., Lei, K. J., Chou, J. Y., & Persico, M. G. (1993) · PubMed · Cited by 313
The Splicing Factor SF2/ASF Regulates Translation Initiation by Enhancing Phosphorylation of 4E-BP1
Michlewski, G., Sanford, J. R., & Cáceres, J. F. (2008) · Molecular Cell · doi:10.1016/j.molcel.2008.03.013 · Cited by 277
Zhou, Z., Qiu, J., Liu, W., Zhou, Y., Plocinik, R. M., Li, H., Hu, Q., Ghosh, G., Adams, J. A., Rosenfeld, M. G., et al. (2012) · Molecular Cell · doi:10.1016/j.molcel.2012.05.014 · Cited by 273
WT1 Mutants Reveal SRPK1 to Be a Downstream Angiogenesis Target by Altering VEGF Splicing
Amin, E. M., Oltean, S., Hua, J., Gammons, M. V. R., Hamdollah-Zadeh, M., Welsh, G. I., Cheung, M.-K., Ni, L., Kase, S., Rennel, E. S., et al. (2011) · Cancer Cell · doi:10.1016/j.ccr.2011.10.016 · Cited by 253
Self-citationInvolvement of SR Proteins in mRNA Surveillance
Zhang, Z., & Krainer, A. R. (2004) · Molecular Cell · doi:10.1016/j.molcel.2004.10.031 · Cited by 237
Utilization of host SR protein kinases and RNA-splicing machinery during viral replication
Fukuhara, T., Hosoya, T., Shimizu, S., Sumi, K., Oshiro, T., Yoshinaka, Y., Suzuki, M., Yamamoto, N., Herzenberg, L. A., Herzenberg, L. A., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0604616103 · Cited by 231
Varey, A. H. R., Rennel, E. S., Qiu, Y., Bevan, H. S., Perrin, R. M., Raffy, S., Dixon, A. R., Paraskeva, C., Zaccheo, O., Hassan, A. B., et al. (2008) · British Journal of Cancer · doi:10.1038/sj.bjc.6604308 · Cited by 226
Self-citationNowak, D. G., Amin, E. M., Rennel, E. S., Hoareau-Aveilla, C., Gammons, M., Damodoran, G., Hagiwara, M., Harper, S. J., Woolard, J., Ladomery, M. R., et al. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.074930 · Cited by 226
Self-citationRB1 gene mutations in retinoblastoma
Lohmann, D. R. (1999) · Human Mutation · doi:10.1002/(sici)1098-1004(199910)14:4<283::aid-humu2>3.0.co;2-j · Cited by 214
TGF-β drives epithelial-mesenchymal transition through δEF1-mediated downregulation of ESRP
Horiguchi, K., Sakamoto, K., Koinuma, D., Semba, K., Inoue, A., Inoue, S., Fujii, H., Yamaguchi, A., Miyazawa, K., Miyazono, K., et al. (2012) · Oncogene · doi:10.1038/onc.2011.493 · Cited by 209
Oncogenic Splicing Factor SRSF1 Is a Critical Transcriptional Target of MYC
Das, S., Anczuków, O., Akerman, M., & Krainer, A. R. (2012) · Cell Reports · doi:10.1016/j.celrep.2011.12.001 · Cited by 202
Alternative Splicing and Tumor Progression
Ghigna, C., Valacca, C., & Biamonti, G. (2008) · Current Genomics · doi:10.2174/138920208786847971 · Cited by 181
RBM5/Luca-15/H37 Regulates Fas Alternative Splice Site Pairing after Exon Definition
Bonnal, S., Martínez, C., Förch, P., Bachi, A., Wilm, M., & Valcárcel, J. (2008) · Molecular Cell · doi:10.1016/j.molcel.2008.08.008 · Cited by 176
Bedford, M. T., Reed, R., & Leder, P. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.18.10602 · Cited by 160
Venables, J. P., Brosseau, J., Gadéa, G., Klinck, R., Prinos, P., Beaulieu, J., Lapointe, E., Durand, M., Thibault, P., Tremblay, K., et al. (2012) · Molecular and Cellular Biology · doi:10.1128/mcb.01174-12 · Cited by 158
Carstens, R. P., Wagner, E. J., & García-Blanco, M. A. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.19.7388-7400.2000 · Cited by 156
Boeckel, J., Guarani, V., Koyanagi, M., Roexe, T., Lengeling, A., SCHERMULY, R. T., Gellert, P., Braun, T. W., Zeiher, A. M., & Dimmeler, S. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1008098108 · Cited by 151
Warzecha, C. C., & Carstens, R. P. (2012) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2012.04.003 · Cited by 144
A positive feedback loop couples Ras activation and CD44 alternative splicingPreprint
Cheng, C., Yaffe, M. B., & Sharp, P. A. (2006) · Genes & Development · doi:10.1101/gad.1430906 · Cited by 144
Expression of VEGFxxxb, the inhibitory isoforms of VEGF, in malignant melanoma
Pritchard‐Jones, R., Dunn, D., Qiu, Y., Varey, A. H. R., Orlando, A., Rigby, H., Harper, S. J., & Bates, D. O. (2007) · British Journal of Cancer · doi:10.1038/sj.bjc.6603839 · Cited by 133
Self-citationShultz, J. C., Goehe, R. W., Wijesinghe, D. S., Murudkar, C. S., Hawkins, A. J., Shay, J. W., Minna, J. D., & Chalfant, C. E. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-1545 · Cited by 132
The endogenous anti-angiogenic VEGF isoform, VEGF165b inhibits human tumour growth in mice
Rennel, E. S., Waine, E., Guan, H., Schüler, Y., Leenders, W. P. J., Woolard, J., Sugiono, M., Gillatt, D. A., Kleinerman, E. S., Bates, D. O., et al. (2008) · British Journal of Cancer · doi:10.1038/sj.bjc.6604309 · Cited by 131
Self-citationSplicing-Factor Oncoprotein SRSF1 Stabilizes p53 via RPL5 and Induces Cellular Senescence
Fregoso, O. I., Das, S., Akerman, M., & Krainer, A. R. (2013) · Molecular Cell · doi:10.1016/j.molcel.2013.02.001 · Cited by 130
Multiple splice variants of lactate dehydrogenase C selectively expressed in human cancer.
Koslowski, M., Türeci, Ö., Bell, C., Krause, P., Lehr, H., Brunner, J., Seitz, G., Nestle, F. O., Huber, C., & Şahin, U. (2002) · PubMed · Cited by 124
Fox-2 Mediates Epithelial Cell-Specific Fibroblast Growth Factor Receptor 2 Exon Choice
Baraniak, A. P., Chen, J. R., & García-Blanco, M. A. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.26.4.1209-1222.2006 · Cited by 118
Gonçalves, V., Matos, P., & Jordan, P. (2009) · Human Molecular Genetics · doi:10.1093/hmg/ddp317 · Cited by 116
Oltean, S., Sorg, B. S., Albrecht, T. R., Bonano, V. I., Brazas, R. M., Dewhirst, M. W., & García-Blanco, M. A. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0603090103 · Cited by 114
Self-citationMerdzhanova, G., Edmond, V., Seranno, S. D., Broeck, A. V. D., Corcos, L., Brambilla, C., Brambilla, E. M., Gazzéri, S., & Eymin, B. (2008) · Cell Death and Differentiation · doi:10.1038/cdd.2008.135 · Cited by 113
Reinke, L. M., Xu, Y., & Cheng, C. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.397125 · Cited by 106
Yea, S., Narla, G., Zhao, X. Y., Garg, R., Kremer-Tal, S., Hod, E. A., Villanueva, A., Loke, J. C., Tarocchi, M., Akita, K., et al. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.02.015 · Cited by 106
Merdzhanova, G., Gout, S., Kéramidas, M., Edmond, V., Coll, J., Brambilla, C., Brambilla, E. M., Gazzéri, S., & Eymin, B. (2010) · Oncogene · doi:10.1038/onc.2010.281 · Cited by 99
Shultz, J. C., Goehe, R. W., Murudkar, C. S., Wijesinghe, D. S., Mayton, E. K., Massiello, A., Hawkins, A. J., Mukerjee, P., Pinkerman, R. L., Park, M. A., et al. (2011) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-11-0061 · Cited by 95
Alternative Splicing of SLC39A14 in Colorectal Cancer is Regulated by the Wnt Pathway
Thorsen, K., Mansilla, F., Schepeler, T., Øster, B., Rasmussen, M. H., Dyrskjøt, L., Karni, R., Akerman, M., Krainer, A. R., Laurberg, S., et al. (2010) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m110.002998 · Cited by 92
Himeji, D., Horiuchi, T., Tsukamoto, H., Hayashi, K., Watanabe, T., & Harada, M. (2002) · Blood · doi:10.1182/blood.v99.11.4070 · Cited by 91
Baraniak, A. P., Lasda, E. L., Wagner, E. J., & García-Blanco, M. A. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.24.9327-9337.2003 · Cited by 91
Gammons, M. V. R., Fedorov, O., Ivison, D., Du, C., Clark, T., Hopkins, C., Hagiwara, M., Dick, A. D., Cox, R. J., Harper, S. J., et al. (2013) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.13-12422 · Cited by 89
Self-citationReeve, J. G., Xiong, J., Morgan, J., & Bleehen, N. M. (1996) · British Journal of Cancer · doi:10.1038/bjc.1996.230 · Cited by 88
Abubaker, J. A., Bavi, P. P., Al‐Haqawi, W., Sultana, M., Al-harbi, S., Al-Sanea, N. A., Abduljabbar, A. S., Ashari, L. H. S., Alhomoud, S. J., Al‐Dayel, F., et al. (2009) · The Journal of Pathology · doi:10.1002/path.2625 · Cited by 86
Alternative splicings on p53, BRCA1 and PTEN genes involved in breast cancer
Okumura, N., Yoshida, H., Kitagishi, Y., Nishimura, Y., & Matsuda, S. (2011) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2011.08.098 · Cited by 80
Identification of ASF/SF2 as a Critical, Allele-Specific Effector of the Cyclin D1b Oncogene
Olshavsky, N. A., Comstock, C. E. S., Schiewer, M. J., Augello, M. A., Hyslop, T., Sette, C., Zhang, J., Parysek, L. M., & Knudsen, K. E. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-3468 · Cited by 77
Cloutier, P., Toutant, J., Shkreta, L., Goekjian, S. R., Revil, T., & Chabot, B. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m800353200 · Cited by 75
Impaired Glomerular Maturation and Lack of VEGF165b in Denys-Drash Syndrome
Schumacher, V., Jeruschke, S., Eitner, F., Becker, J. U., Pitschke, G., Ince, Y., Miner, J. H., Leuschner, I., Engers, R., Everding, A. S., et al. (2007) · Journal of the American Society of Nephrology · doi:10.1681/asn.2006020124 · Cited by 74
Zhang, K., Nowak, I., Rushlow, D., Gallie, B. L., & Lohmann, D. R. (2008) · Human Mutation · doi:10.1002/humu.20664 · Cited by 73
Anticancer drugs affect the alternative splicing of Bcl-x and other human apoptotic genes
Shkreta, L., Froehlich, U., Paquet, É. R., Toutant, J., Elela, S. A., & Chabot, B. (2008) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-08-0192 · Cited by 69
Wang, H., Zhou, M., Shi, B., Zhang, Q., Jiang, H., Sun, Y., Liu, J., Zhou, K., Yao, M., Gu, J., et al. (2011) · Neoplasia · doi:10.1593/neo.101744 · Cited by 68
Rouas‐Freiss, N., Bruel, S., Menier, C., Marcou, C., Moreau, P., & Carosella, E. D. (2005) · International Journal of Cancer · doi:10.1002/ijc.21151 · Cited by 63
Díaz, R., Peña, C., Silva, J., Lorenzo, Y., García‐Barberán, V., García, J. M., Sánchez, A., Lara, P. E., Yuste, R. S., Bonilla, F., et al. (2008) · International Journal of Cancer · doi:10.1002/ijc.23619 · Cited by 55
Oltean, S., Febbo, P. G., & García-Blanco, M. A. (2008) · Clinical & Experimental Metastasis · doi:10.1007/s10585-008-9186-y · Cited by 39
Self-citationKonrad, L., Scheiber, J. A., Völck‐Badouin, E., Keilani, M. M., Laible, L., Brandt, H., Schmidt, A., Aumüller, G., & Hofmann, R. W. (2007) · BMC Genomics · doi:10.1186/1471-2164-8-318 · Cited by 34
Ergorul, C., Ray, A., Huang, W. C., Darland, D. C., Luo, Z. K., & Grosskreutz, C. L. (2008) · PubMed · Cited by 34
The Proto-oncogene PKCι Regulates the Alternative Splicing of Bcl-x Pre-mRNA
Shultz, J. C., Vu, N., Shultz, M. D., Mba-Uzoma, U., Shapiro, B. A., & Chalfant, C. E. (2012) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-11-0363 · Cited by 28
Exon 11 Skipping of E-Cadherin RNA Downregulates Its Expression in Head and Neck Cancer Cells
Sharma, S., Liao, W., Zhou, X. C., Wong, D. T., & Lichtenstein, A. K. (2011) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-11-0248 · Cited by 28
Amor, S., Rémy, S., Dambrine, G., Vern, Y. L., Rasschaert, D., & Laurent, S. (2010) · BMC Cancer · doi:10.1186/1471-2407-10-571 · Cited by 22
Rha, S. Y., Jeung, H., Park, K.-H., Kim, J. J., & Chung, H. C. (2009) · Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics · doi:10.3727/096504009x12596189659123 · Cited by 17
Xu, J., Wang, Y.-C., Geng, X., Li, Y., & Zhang, W. (2009) · Pathobiology · doi:10.1159/000178152 · Cited by 15
Cited by
Bueno, R., Stawiski, E. W., Goldstein, L. D., Durinck, S., De Rienzo, A., Modrusan, Z., Gnad, F., Nguyen, T. T., Jaiswal, B. S., Chirieac, L. R., et al. (2016) · Nature Genetics · doi:10.1038/ng.3520 · Cited by 919
Roles and mechanisms of alternative splicing in cancer — implications for care
Bonnal, S. C., López-Oreja, I., & Valcárcel, J. (2020) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-020-0350-x · Cited by 731
Alternative splicing and cancer: a systematic review
Zhang, Y., Qian, J., Gu, C., & Yang, Y. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00486-7 · Cited by 497
Aberrant RNA splicing in cancer; expression changes and driver mutations of splicing factor genes
Sveen, A., Kilpinen, S., Ruusulehto, A., Lothe, R. A., & Skotheim, R. I. (2016) · Oncogene · doi:10.1038/onc.2015.318 · Cited by 470
Perspective on Oncogenic Processes at the End of the Beginning of Cancer Genomics
Ding, L., Bailey, M. H., Porta-Pardo, E., Thorsson, V., Colaprico, A., Bertrand, D., Gibbs, D. L., Weerasinghe, A., Huang, K.-L., Tokheim, C., et al. (2018) · Cell · doi:10.1016/j.cell.2018.03.033 · Cited by 399
Metadata
- Authors
- Oltean, S., & Bates, D. O.
- Venue
- Oncogene
- Published
- 2013-12-16
- Volume
- 33
- Issue
- 46
- Pages
- 5311-5318
- ISSN
- 0950-9232 (ISSN-L)
- 1476-5594
- OpenAlex
- W2009258895
- Cited by
- 664
- References
- 92
- FWCI
- 12.64
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.